Fundraising FoxSignet Healthcare Partners — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Cerium Pharmaceuticals develops and commercializes medicines for rare or "orphan" diseases, including kidney disease.
BiotechHealthtechGaithersburg, US
Gregg Lapointe(Co-Founder & Chief Executive Officer)inRobert J. Rubin(Co-Founder & Interim CMO)Nancy Klett(Co-Founder & Chief Operating Officer)inŞemsi Burak Derkunt(Chief Scientific Officer)inBrian Schreiber(Chief Medical Officer (2015 to 2021))inPeter Collum(Director)
Board seatJames Gale· per SEC Form D · $10.1M raise · filed Jul 2021
FemTechHealthtechMedical DevicesRedwood City, US
Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)
BoardKen Haas(Director)Jonathan MacQuitty(Director)inMike Carusi(Director)inDoug Fisher(Director)
Board seatJoyce Erony· per SEC Form D · $50M raise · filed Dec 2021
Co-investorsAmzak HealthBain Capital Life SciencesEndeavour VisionFemHealth VenturesKaiser Permanente VenturesKluz Ventures+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.